ArticleAdvances in hematology2025
Positive Indirect Antiglobulin Test in Adult Patients With Primary Warm Autoimmune Hemolytic Anemia: Clinical Significance and Prognostic Effect on Response to Corticosteroids.
Article in Advances in hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary warm autoimmune hemolytic anemia (PWAIHA) is a subtype of autoimmune hemolytic anemia (AIHA) characterized by premature destruction of red blood cells (RBCs) due to autoantibodies, typically immunoglobulin G (IgG), the cornerstone of which is a positive direct antiglobulin test. The indirect antiglobulin test (IAT) is used as a screening test to detect common and clinically significant RBC alloantibodies in patient serum. Objective: This study aimed to analyze the prevalence, clinical characteristics, and impact of positive IAT in adult patients with PWAIHA at the time of diagnosis, as well as the response to corticosteroids as the first-line treatment. Methods: This single-center retrospective case-control study was conducted between September 2002 and May 2024 at King Abdullah University Hospital. We analyzed data from 80 adult patients diagnosed with PWAIHA, aged a minimum of 16 years. After recording baseline investigations, including IAT and antinuclear antibody (ANA), all patients were treated with corticosteroids as first-line treatment. The response rate and prevalence of ANA were compared between the IAT-positive and -negative PWAIHA groups. Results: Baseline IAT positivity was found in 65% of our patients. Both groups were comparable in terms of age, sex, and hemoglobin levels. Serum LDH presentations were higher in positive IAT patients, response to corticosteroids was numerically higher in patients with negative IAT (54%) than those with positive IAT (33%), and after tapering steroids, patients with a positive IAT had higher rates of relapses compared with those with negative IAT. Positive ANA was found only in IAT-positive patients (25%), which was statistically significant. Conclusion: An association between baseline IAT positivity and lower rates of complete response was observed in PWAIHA patients. The presence of IAT serves as a prognostic indicator and aids in the decision-making process regarding treatment options. Furthermore, positive IAT results are linked to a higher prevalence of ANA positivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.